NO313287B1 - Fremgangsmåter for fremstilling av HIV-protease inhibitorer - Google Patents

Fremgangsmåter for fremstilling av HIV-protease inhibitorer Download PDF

Info

Publication number
NO313287B1
NO313287B1 NO19991072A NO991072A NO313287B1 NO 313287 B1 NO313287 B1 NO 313287B1 NO 19991072 A NO19991072 A NO 19991072A NO 991072 A NO991072 A NO 991072A NO 313287 B1 NO313287 B1 NO 313287B1
Authority
NO
Norway
Prior art keywords
group
formula
compound
alkyl
aryl
Prior art date
Application number
NO19991072A
Other languages
English (en)
Norwegian (no)
Other versions
NO991072L (no
NO991072D0 (no
Inventor
Kathleen R Whitten
Michael E Deason
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of NO991072L publication Critical patent/NO991072L/no
Publication of NO991072D0 publication Critical patent/NO991072D0/no
Publication of NO313287B1 publication Critical patent/NO313287B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19991072A 1996-09-05 1999-03-04 Fremgangsmåter for fremstilling av HIV-protease inhibitorer NO313287B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05
PCT/US1997/015468 WO1998009951A2 (en) 1996-09-05 1997-09-04 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors

Publications (3)

Publication Number Publication Date
NO991072L NO991072L (no) 1999-03-04
NO991072D0 NO991072D0 (no) 1999-03-04
NO313287B1 true NO313287B1 (no) 2002-09-09

Family

ID=24845703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991072A NO313287B1 (no) 1996-09-05 1999-03-04 Fremgangsmåter for fremstilling av HIV-protease inhibitorer

Country Status (33)

Country Link
EP (2) EP0927165B1 (xx)
JP (3) JP4149000B2 (xx)
KR (1) KR100563289B1 (xx)
CN (2) CN1183117C (xx)
AP (2) AP2003002938A0 (xx)
AT (2) ATE254603T1 (xx)
AU (2) AU740369B2 (xx)
BG (2) BG64793B1 (xx)
BR (1) BR9713192A (xx)
CA (1) CA2264756A1 (xx)
CZ (2) CZ298175B6 (xx)
DE (2) DE69734689T2 (xx)
DK (2) DK1361216T3 (xx)
EA (1) EA002051B1 (xx)
EE (1) EE04465B1 (xx)
ES (2) ES2210573T3 (xx)
GE (1) GEP20022799B (xx)
HK (1) HK1062171A1 (xx)
HU (1) HUP0000028A3 (xx)
IL (1) IL128567A (xx)
IS (1) IS2030B (xx)
NO (1) NO313287B1 (xx)
NZ (1) NZ334909A (xx)
OA (1) OA10988A (xx)
PL (2) PL198408B1 (xx)
PT (1) PT927165E (xx)
SG (1) SG94780A1 (xx)
SI (2) SI1361216T1 (xx)
SK (2) SK284899B6 (xx)
TR (1) TR199900473T2 (xx)
UA (1) UA67727C2 (xx)
WO (1) WO1998009951A2 (xx)
YU (1) YU11599A (xx)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
WO1996028423A1 (fr) * 1995-03-15 1996-09-19 Sankyo Company, Limited Composes dipeptidiques de structure ahpba
AU717637B2 (en) * 1995-09-26 2000-03-30 Agouron Pharmaceuticals, Inc. Production of amide derivatives and intermediates therefor
WO1997011938A1 (fr) * 1995-09-26 1997-04-03 Japan Tobacco Inc. Procede de production de derives amides et de leurs intermediaires
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
US5925767A (en) * 1996-02-24 1999-07-20 Basf Aktiengesellschaft Pyrazole-4-yl-hetaroyl derivatives as herbicides

Also Published As

Publication number Publication date
SK28299A3 (en) 1999-11-08
BG64793B1 (bg) 2006-04-28
SI0927165T1 (en) 2004-04-30
DK0927165T3 (da) 2004-03-15
CZ298174B6 (cs) 2007-07-11
DE69726298T2 (de) 2004-05-27
YU11599A (sh) 2000-03-21
KR20010029489A (ko) 2001-04-06
HUP0000028A3 (en) 2003-05-28
HK1062171A1 (en) 2004-10-21
NO991072L (no) 1999-03-04
BR9713192A (pt) 1999-12-21
BG103305A (en) 2000-01-31
IL128567A (en) 2004-03-28
NO991072D0 (no) 1999-03-04
SG94780A1 (en) 2003-03-18
SI1361216T1 (sl) 2006-02-28
EE04465B1 (et) 2005-04-15
GEP20022799B (en) 2002-09-25
OA10988A (en) 2001-11-01
AP2003002938A0 (en) 2003-12-31
ATE309990T1 (de) 2005-12-15
CN1232455A (zh) 1999-10-20
CN1183117C (zh) 2005-01-05
BG65237B1 (bg) 2007-09-28
DE69726298D1 (de) 2003-12-24
CN1537846A (zh) 2004-10-20
ATE254603T1 (de) 2003-12-15
IL128567A0 (en) 2000-01-31
AU740369B2 (en) 2001-11-01
EP1361216A1 (en) 2003-11-12
SK285278B6 (sk) 2006-10-05
TR199900473T2 (xx) 1999-06-21
PL201758B1 (pl) 2009-05-29
EA199900257A1 (ru) 1999-08-26
ES2252586T3 (es) 2006-05-16
PL331801A1 (en) 1999-08-02
IS4982A (is) 1999-02-19
SK284899B6 (sk) 2006-02-02
JP2008056693A (ja) 2008-03-13
AP9901497A0 (en) 1999-06-30
CZ298175B6 (cs) 2007-07-11
WO1998009951A3 (en) 1998-07-09
ES2210573T3 (es) 2004-07-01
CZ71699A3 (cs) 1999-06-16
AU766155B2 (en) 2003-10-09
AU1473602A (en) 2002-03-14
PT927165E (pt) 2004-04-30
JP4149000B2 (ja) 2008-09-10
CN1305854C (zh) 2007-03-21
AP1322A (en) 2004-11-04
AU4331797A (en) 1998-03-26
EP1361216B1 (en) 2005-11-16
DE69734689T2 (de) 2006-06-08
HUP0000028A2 (hu) 2000-05-28
IS2030B (is) 2005-08-15
CA2264756A1 (en) 1998-03-12
DE69734689D1 (de) 2005-12-22
PL198408B1 (pl) 2008-06-30
EA002051B1 (ru) 2001-12-24
WO1998009951A2 (en) 1998-03-12
DK1361216T3 (da) 2006-01-23
EE9900109A (et) 1999-12-15
JP2008088178A (ja) 2008-04-17
KR100563289B1 (ko) 2006-03-22
UA67727C2 (uk) 2004-07-15
JP2001500495A (ja) 2001-01-16
EP0927165A2 (en) 1999-07-07
EP0927165B1 (en) 2003-11-19
NZ334909A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
DK158980B (da) Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK154555B (da) Analogifremgangsmaade til fremstilling af carbazolyl-(4)-oxy-propanolaminderivater eller deres farmakologisk anvendelige salte
JPS6058750B2 (ja) N−(1−ベンジルピロリジニル−2−メチル)置換ベンズアミド誘導体またはその塩類の製造法
RU2137769C1 (ru) Способ получения эпоксида
US6512135B2 (en) Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
CA2264725A1 (en) Methods of making hiv-protease inhibitors and intermediates for making them
NO313287B1 (no) Fremgangsmåter for fremstilling av HIV-protease inhibitorer
US7078543B2 (en) Methods for producing oxirane carboxylic acids and derivatives thereof
KR900004144B1 (ko) 1,2,5,6-테트라히드로-4H-피롤로[3,2,1-ij]퀴놀린-4-온의 제조방법
US2459111A (en) Pantoyltauramides and preparation of the same
JP4788049B2 (ja) ジカルボン酸ジエステル誘導体およびその製造方法
SU1124885A3 (ru) Способ получени производных дихлорацетилированного вторичного амида
KR800001133B1 (ko) 복소환 치환기를 가진 5-설파모일벤조산 유도체의 제조방법
JPH0583537B2 (xx)
DUMITRAŞCU et al. Synthesis and NMR study of 2-[N-(aryl) carbamoylmethyl] phthalazinium iodides
JPS6110555A (ja) 随時置換されたベンズ[c,d]インドル‐2‐オンの製造法
JPH02300154A (ja) 安息香酸誘導体の製造法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees